Bioxytran, Inc.
BIXT
$0.16
$0.00332.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.11% | 66.86% | 54.28% | -1.94% | -27.84% |
| Total Depreciation and Amortization | -23.68% | -16.67% | -31.82% | 300.00% | 322.22% |
| Total Amortization of Deferred Charges | -- | -- | -91.39% | -- | -100.00% |
| Total Other Non-Cash Items | 20.92% | -85.56% | 468.38% | 2,434.20% | -1,305.88% |
| Change in Net Operating Assets | -91.98% | -30.08% | -45.34% | -55.88% | 75.13% |
| Cash from Operations | 147.62% | 108.81% | 64.45% | 59.55% | 40.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.33% | 28.35% | 94.58% | -27.66% | -214.29% |
| Cash from Investing | -83.33% | 28.35% | 94.58% | -27.66% | -214.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -48.70% | -- | -93.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -236.67% | -100.00% | -9.23% | 31.00% | -43.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.57% | -39.60% | 103.22% | 88.63% | 31.22% |